Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Vago

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|December 15, 2025
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experienceGregorio Maria Bergonzi, Enrico Cozzo, Alessandro Tomelleri, et al.
Cancer Discovery|March 7, 2022
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and RelapseValentina Gambacorta, Stefano Beretta, Martina Ciccimarra, et al.
Frontiers in Oncology|July 9, 2024
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experienceElisa Diral, Giulia Furnari, Alessandro Bruno, et al.
American Journal of Hematology|June 21, 2017
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioningAvichai Shimoni, Luca Vago, Massimo Bernardi, et al.
Circulation|October 13, 2004
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarctionRoberto Latini, Aldo P Maggioni, Giuseppe Peri, et al.
The Journal of Experimental Medicine|October 28, 2009
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CThorsten Graef, Achim K Moesta, Paul J Norman, et al.
Haematologica|October 15, 2020
Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective studyValentina Gambacorta, Riccardo Parolini, Elisabetta Xue, et al.
Leukemia|May 16, 2020
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaFrancesca Lorentino, Myriam Labopin, Fabio Ciceri, et al.
Blood|March 5, 2015
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantationNicoletta Cieri, Giacomo Oliveira, Raffaella Greco, et al.
Current Research in Translational Medicine|October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal typeLorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|December 15, 2025
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experienceGregorio Maria Bergonzi, Enrico Cozzo, Alessandro Tomelleri, et al.
Cancer Discovery|March 7, 2022
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and RelapseValentina Gambacorta, Stefano Beretta, Martina Ciccimarra, et al.
Frontiers in Oncology|July 9, 2024
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experienceElisa Diral, Giulia Furnari, Alessandro Bruno, et al.
American Journal of Hematology|June 21, 2017
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioningAvichai Shimoni, Luca Vago, Massimo Bernardi, et al.
Circulation|October 13, 2004
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarctionRoberto Latini, Aldo P Maggioni, Giuseppe Peri, et al.
The Journal of Experimental Medicine|October 28, 2009
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CThorsten Graef, Achim K Moesta, Paul J Norman, et al.
Haematologica|October 15, 2020
Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective studyValentina Gambacorta, Riccardo Parolini, Elisabetta Xue, et al.
Leukemia|May 16, 2020
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaFrancesca Lorentino, Myriam Labopin, Fabio Ciceri, et al.
Blood|March 5, 2015
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantationNicoletta Cieri, Giacomo Oliveira, Raffaella Greco, et al.
Current Research in Translational Medicine|October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal typeLorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Pageof 12